chrisvoncsefalvay/vaers-outcomes huggingface dataset:
aches; Fever (101.9); fatigue; nausea; chills; "ice pick" migraines severe; This is a spontaneous report from a contactable consumer (patient) or other non HCP.    A 54-years-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8731), via an unspecified route, administered in arm left on 14Apr2021 at 20:00 PM (age at vaccination was 54 years-old) as DOSE 2, SINGLE for covid-19 immunization. Medical history included Prior migraines (ceased with menopause) from an unknown date and unknown if ongoing. No known allergies were reported. Concomitant medications included omeprazole, rosuvastatin, vitamin d [vitamin d nos]; all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. Facility type vaccine was pharmacy or drug store. No other vaccines were received within four weeks prior to the administration of bnt162b2. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8730), via an unspecified route, administered in arm left on 23Mar2021 at 02:00 PM (age at vaccination was 54 years-old) as DOSE 1, SINGLE for covid-19 immunization. On 22Apr2021 at 08:30 AM, the patient experienced fever (101.9), aches, chills, fatigue, nausea, ice pick migraines-severe. The adverse events lasted for approximate 36 hours. No treatment was received for the events. The patient underwent lab tests and procedures which included body temperature: 101.9 (fever) on 22Apr2021. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
No adverse symptoms, patient was under 18 when the vaccine was given him.  Patient scheduled on line so he was checked in online and it was not until we had logged the information that we became aware that he was under 18.
intermittent dizziness which led to temporary instability in standing; intermittent dizziness which led to temporary instability in standing; instability in standing; generalized muscle stiffness around the neck/shoulder/upper back area; low grade fever; develop low grade fever, fatigue and generalized muscle and joint aches; develop low grade fever, fatigue and generalized muscle and joint aches; generalized muscle and joint aches; patient developed palpitation and nervousness; patient developed palpitation and nervousness; difficulty falling asleep; mild arm pain; This is a spontaneous report from a contactable Pharmacist. A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an intramuscular route of administration in left arm on 11May2021 at 16:30 (age at vaccination 36-year-old) as single dose for COVID-19 immunization. The patient's medical history was not reported. List of any other medications the patient was not received within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an intramuscular route of administration in left arm on 20Apr2021 (age at vaccination 36-year-old) at single dose for COVID-19 immunization. On 11May2021 after the injection, patient developed mild arm pain around 21:00, after the injection. On 11May2021 around 23:00, patient developed palpitation and nervousness, which led to difficulty falling asleep for that night. The next day on 12May2021 morning patient experienced generalized muscle stiffness around the neck/shoulder/upper back area. On 12May2021 patient started to develop low grade fever, fatigue and generalized muscle and joint aches. These symptoms are ongoing. On 13May2021 patient additionally developed intermittent dizziness which led to temporary instability in standing. The instability in standing recovered. The dizziness still ongoing. The patient did not receive any treatment for adverse event. The outcome of event intermittent dizziness which led to temporary instability in standing was recovered on 13May2021 and the outcome of all other event was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
received a diagnosis of pertussis today despite getting vaccinated on 1/3/19.; pertussis; This case was reported by a other health professional via sales rep and described the occurrence of suspected vaccination failure in a 57-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number TF422, expiry date unknown) for prophylaxis.   On 1st March 2019, the patient received Boostrix. On 13th April 2020, 409 days after receiving Boostrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and pertussis were unknown.   It was unknown if the reporter considered the vaccination failure and pertussis to be related to Boostrix.  Additional details were provide as follows: This case was reported by patient himself. The age at vaccination was not reported. The patient was diagnosis with pertussis. The reporter consented to follow up. This case was considered as suspected vaccination failure as details regarding primary vaccination schedule were unknown at the time of reporting.
sore arm, fever, chills, headache, nausea, diarrhea (2 days) loss of appetite (3 days)
[May 7] Persistent headache in bottom back of headache, beginning in the morning. Around 5pm, headache intensified and I almost called a doctor, thinking  something had ruptured. The next 2 days [May 8, May 9], I experienced a couple nosebleeds.
I was seated, looking forward and my right eye started moving of its own accord, I could still see but everything was blurry through the  right eye (it felt like when you cross your eyes, though it was only my right eye, and it was doing it all by itself). I stood up and felt light headed and a bit of vertigo. After about three minutes my eye could see mostly normal again and the vertigo/strange feeling in my head stopped. My eyes were both sore and watering for three days afterward, I took the next day off work as I could not stare at the computer screen. For that night and the next few days I felt like my pupils stayed small (did not dilate) even in the dark, I have never had anything like that happen before, and there is nothing else that I can think of to attribute it to.
Pain around my waist, movement was limited, I could hardly stretch because of the pain, numbness going down my right upper thigh and to my ankle, burning in my calf muscle, extremely painful to walk, I went to a nerve and spine doctor around June 2021. I was prescribed Gabapentin and Cyclobenzaprine.
Difficulty breathing, hoarseness, wheezing, fast heartbeat, swelling/throat tightness, redness in face, feeling of pain/warmth in ears, sinus pain, headache, red/itchy eyes.
Pt received DTap, Hib,IPV, Prevnar (1st doses each). Mother called me 11/14 with report of rash on face that looked like a bug bite, comes and goes. Into office 11/15 with ongoing rash of same description on face and trunk. Exam was normal, but descriptions is consistent with hives.
Moderna COVID-19 Vaccine EUA: Vaccine recipient received vaccine on Friday (2/18/2022). About 24 hours later on Saturday reported she had pain in her right wrist and forearm of the arm where the vaccine was administered. With this pain I started with a mild tremor of my right hand. She is still having the tremor as of 3/14/2022. She has a primary care visit follow-up.
Pt received her first dose Pfizer Covid 19 vaccine and was currently being monitored in the observation area for 30 minutes when she developed vasovagal symptoms- diaphoresis, near syncopal episode and hypotension. EMS and nurses responded with the event. initial BP = 90/40. Pt was transferred immediately to the treatment room, was placed on supine position and was further monitored. Pt relates she has these symptoms every time she has her blood drawn. Repeat BP=106/56 after 5 mins. Pt became better after 15 mins, BP=127/68, pulse ox=98 RA, pulse=70.
it was not even as sore as before with the other shots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 (Lot number: EN6203, Expiration Date: 30Jun2021) at the age of 73 years as dose 1, single and administered in arm left, administration date 18Mar2021 (Lot number: EN6207, Expiration Date: 31Jul2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "arthritis" (unspecified if ongoing). Concomitant medication(s) included: PREDNISONE taken for arthritis. Vaccination history included: Flu shot (Caller reports she takes flu shots every year and no reactions to report). The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "it was not even as sore as before with the other shots".  Additional information:Investigation Assessment was no.It was reported that  the soreness lasted a few days but it was not even as sore as before with the other shots though that might had been because she is taking prednisone due to arthritis. Patient  reports she takes flu shots every year and no reactions to report.Additional Vaccines Administered on Same Date of the Pfizer Suspect was  none. Emergency Room and Physician Office visit was no.AE(s) following prior vaccinations: sore arm, tired.Relevant Tests were none.  No follow-up attempts are possible. No further information is expected.
Initial edema  at injection site size of quarter/ecchymosis. At day #7 3x5 cm Induration, warmth and tenderness, ecchymosis fading.  Saw doctor, prescribed Keflex for potential cellulitis.
Rash and itching - took BENADRYL. Joint achiness - TYLENOL.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unspecified date in 2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended. Instead the patient contracted a persistent strain of shingles, or herpes zoster. Later in 2016, the patient was treated by a physician for the onset of a severe vesicular rash which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the defective ZOSTAVAX and/or as a result of the tenuous efficacy of the vaccine, the patient suffered painful injuries and damages, and required extensive medical care and treatment. Further, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Throbbing in thoracic area; Burning sensation in thoracic area; discomfort; This case was reported by a consumer via call center representative and described the occurrence of throbbing pain in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of rash (On an unknown date patient received 1st dose of Shingrix. Refer case US2022AMR137792).   In September 2022, the patient received the 2nd dose of Shingrix. In September 2022, less than a week after receiving Shingrix, the patient experienced throbbing pain, burning sensation and discomfort. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the throbbing pain and burning sensation were not recovered/not resolved and the outcome of the discomfort was unknown.   It was unknown if the reporter considered the throbbing pain, burning sensation and discomfort to be related to Shingrix.     Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's Comments:  The patient reported that, she received her second dose of Shingrix about two weeks ago of reporting in her left arm.   The patient had been experiencing a throbbing, burning sensation in the thoracic area of her body for about one week.   She stated this in the area where her bra was.  She took Tylenol for the discomfort The patient had a back x-ray done which was negative.   The reporter gave consent to follow up. For 1st dose refer case US2022AMR137792.; Sender's Comments:  US-GSK-US2022AMR137792:Same reporter
Patient was already immune to hepatitis A, based on Hepatitis A Ab test that came back positive in March of 2017. However, the Hepatitis A-Hepatitis B combination vaccine was administered in 4/2017 despite known Hepatitis A immunity.
Client had #1 hep b immunization on 05/16/02. Contacted clinic on 05/09/02 with c/o flu-like symptoms and was wondering if this was a reaction to vaccine, stated she had also been exposed to the flu. Client was reassurred and was given the option not to continue the series. Client elected to continue and similar s/s resulted from 2nd immunization. Symptoms continue at 10am but are no worse.
This case was reported by a physician and described the occurrence of injection site hives in a 6-month-old female subject who was vaccinated with PEDIARIX. On an unspecified date, the subject received an unspecified dose of PEDIARIX (unknown). Forty-eight hours after vaccination with PEDIARIX, the subject experienced injection site hives. At an unspecified time after vaccination with PEDIARIX, the subject developed hives all over body. The subject was treated with BENADRYL and the hives resolved after an unspecified period of time. The reporter was an allergist, who was contacted by the subject's physician. Thus, no further information was available on the infant subject.
patient reported today on 01/25/2022 that she has had a flat intchy rash on abdomen, chest, neck for 3 weeks post initial vaccine. She was recommended to follow up wthi MD or urgent car before getting any further covid vaccine
Information has been received from a county health registered nurse concerning a 9 year old male who on 08-MAR-2000 was vaccinated with varicella virus vaccine live (Oka/Merck). On 23-MAR-2007 the patient developed varicella, < 50 lesions. The nurse reported that an outbreak of varicella had taken place in the local school district in April 2007, and this student was identified during the county health investigation. An immunization clinic was conducted in the school where students received a second dose of varicella virus vaccine live (Oka/Merck). This is one of 28 reports received from the same source. No further information is available.
Feeling fluish; Feeling crappy all over; This case was reported by a consumer and described the occurrence of influenza like illness in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles (he gets a lot shingles outbreaks often).   On 3rd February 2023, the patient received the 1st dose of Shingrix. On 22nd February 2023, 19 days after receiving Shingrix, the patient experienced influenza like illness and feeling unwell. On an unknown date, the outcome of the influenza like illness and feeling unwell were not recovered/not resolved.   It was unknown if the reporter considered the influenza like illness and feeling unwell to be related to Shingrix.     Additional Information: GSK Receipt Date: 22-FEB-2023 Reporter's Comment: The reporter was a patient wife. The reporter reported that the patient was waited to receive his shingles vaccine for a long while and by the time he finally got a date and time to go and get the vaccine. The reporter stated that the patient was broke out with scalp shingles and a little bit on his lower back bone where he commonly get the shingles on regular basis so the patient stuck with the physician appointment. The reporter reported that when the patient received Shingrix vaccine he had an active case of shingles. The reporter stated that on 19th February 2023, 19 days after received Shingrix vaccine the patient experienced feeling fluish and just crappy all over. The patient done with the laboratory test Covid 19 test just in case with result negative. The reporter wanted to know if the patient going to be okay, or if he will need to get yet another shot after this outbreak finally leaves him. The reporter requested to consent the follow up.
Information regarding PREVNAR 13 was received from a physician regarding an unknown number of patients who experienced very painful injection sites. The patient received a dose on unspecified dates. Relevant medical history was not provided. Concomitant medications were not reported. The patients experienced very painful injection sites. Outcome was unknown. No additional information was available at the time of this report.
Upper respiratory tract infection, unspecified type  Acute non-recurrent sinusitis, unspecified location  COVID-19
Had the vaccine, had no reactions, and then a few days later starting on the left arm at the elbow, moving down his forearm had a red rash and itching.  He now has the red rash and itching on both forearms.   He had this same reaction from taking Bactrim in the past.  It normally goes away in 2-3 days, but he can't seem to stop this reaction and it's itching.  The Benadryl has slowed it down some but has not stopped it.
24 hours after first dose vaccine developed headache.  48 hours after vaccine developed left sided facail pain and cervico-occipital swelling.  Diagnosed with Trigeminal Neuralgia by PCP on 7-9-2021.  Referred to Neurologist on 7/10/2021 and placed on Tegretol.  Symptoms improving by 8/6/2021.
DTaP #5 given on 4/12/06. On 4/14/06 mom brought child to clinic with right arm swollen, reddened and warm. Child has no difficulty moving arm.
This is a report of an adverse reaction to Comvax given on 1/30/01. The mother reports that within 4-6 hours, post vax, she developed a fever of 102F and redness and swelling of the right thigh. The infant was initially seen  in ER late PM on 1/30/01 and dx'd with a local reaction to Comvax. She was treated symptomatically with oral Motrin and Benadryl. The fever resolved over the next 12 hours but the redness and swelling of leg worsened. The parents brought the child back to ER on 2/3/01 to be rechecked. Physical exam revealed no fever, continued redness and swelling of the right leg as well as some induration. The ER physician then consulted child's pediatrician to see child. On my exam, she was fine except for right thigh dorsally with a 4cm X 6cm area of erythema and swelling with a 2cm area of induration. Dx at that time was local reaction to Comvax with mild cellulitis. Infant was treated with oral Duricef. The infant was examined again on 2/4/01 and 2/5/01 with a slow gradual improvement of local redness and swelling. The infant used the leg normally but seemed to have some tenderness especially with motion. The infant did not come for scheduled follow-up appointment on 2/15/01. The parents have been contacted to reschedule the visit.
Events: chills, aches, headache, insomnia Treatment: none Outcome: most symptoms gone within 24 hours
Can't sleep; Muscle pain arm for over 2 weeks was not at the time of shoot. Just started recently 2 weeks ago.; This is a spontaneous report from a contactable consumer (patient). A 41-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: unknown) via an unspecified route of administration on 04Jun2021 at 14:00 (at the age of 41-years-old) in right arm as a single dose for covid-19 immunization. Medical history included thyroid removal from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with covid-19. No known allergies were reported. Concomitant medication received in two weeks included levothyroxine sodium (LEVOTHYROXINE SODIUM) taken for an unspecified indication, start and stop date were not reported. The patient's historical vaccine received within four weeks included first dose of BNT162B2 (COVID Pfizer vaccine; lot number: unknown) on an unspecified date for covid-19 immunization. On 01Jul2021 the patient experienced muscle pain in arm for over 2 weeks and it was not at the time of shoot. She also reported that she can't sleep. The patient did not receive any treatment for the events. Post vaccination, the patient had been tested for covid-19. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab) as negative on 19Jun2021. The outcome of the events was not recovered.  Information on the Batch/Lot number has been requested.
Began having severe h/a & entire pain all over body on 9JUN91PM; MD called for consultation & said rxn did sound like rxn to MMR & if cont until tomorrow to come to office;
Couldn?t stop myself from yelling out when I  was trying to sleep but  still awake.  I was yelling out random words and some moans. I tried to stop but words just popped out. Okay, mom, hey...  loud enough to wake family members in next room. I couldn?t get restful sleep and kept getting up yelling for about an hour. I took 2 Tylenol then I was able to sleep and stopped yelling.  Otherwise, I had the usual fatigue, nausea, site swelling & pain, slight headache.  Still sleeping it off at hour 50.
Sharp stabbing pain felt at bottom of sternum; acute onset, lasting approximately 3 hours. I am an RN and would describe by symptoms as being like costochondritis. Took ibuprofen. Pain resolved an hour later; chest felt tight for the rest of the evening. Symptoms occurred approximately 7-8 hours after getting the flu shot.
Headache, hot flashes, restlessness, fatigue. All symptoms lasted about 12 hours, except hot flashes (which lasted about 16 hours) and fatigue (which continued for a couple of days).
2-3hrs after the vaccine I started feeling pain in my lungs it was a 6 or 7 out of 10 pain. I also had arm soreness. My lung pain started getting better day by day but I still have a little pain here and there. I saw my doctor on base we did breathing treatments it was like Asthma treatment.
Narrative:  Death on 5/13/2021 approximately 3 months after 2nd dose of Pfizer vaccine. 68-year-old patient admitted to hospital for hospice/end of life care on 04/15. Newly diagnosed with hepatocellular carcinoma, with very limited treatment options, declining further life-prolonging therapy. No indication that death was due to vaccine
Swollen , redness at injection site. Cellulitis -looking skin.  No systemic symptoms reported .
Localized red painful erythema at injection site. 2 injections given in the R arm. #1 2cm oval diameter red not raised, no vesicles noted. #2 1cm in diameter and inferior on arm to #1.
Large red area on upper left arm with some swelling, near injection site.  Muscle pain at the site, area very hot to the touch -- actually 2 degrees hotter than the same part of my other arm.  Upon arising the morning after having this vaccine, my usual aches and pains were much worse than usual.  Painful joints of toes, arches, ankles, knees, neck and shoulders.  Some dizziness caused me to go back to bed for a while longer.   After light breakfast, I took my usual morning supplements, including 2 extra-strength acetaminophen and 3 ibuprofen tablets for pain and inflammation.   I felt terrible all day long; unsteady and weak.  I took more pain relief caps in th evening. This is the third day after the shingles vaccine, and the arm is still very painful and HOT.